Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen dealThe deal is a bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.[Collection]

The deal is a bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.https://www.cnbc.com/2023/05/16/horizon-therapeutics-amgen-deal-ftc.html